InvestSMART

ImExHS Limited (ASX:IME)

ALERT: Price-sensitive ASX Announcement for IME
Current share price for IME : $0.385 0.15 (63.83%)+
Release
26 Sep 2025 8:27AM
Price at Release
$0.235
Full Release
download
Summary
IMEXHS Limited has signed a new contract with Oncolife, a healthcare provider in Colombia, to deliver high-complexity radiology services. The contract, effective immediately for one year, is expected to generate approximately A$1.4 million in New Annual Recurring Revenue. It involves deploying IMEXHS' RIS/PACS platform, a patient portal, and AI diagnostic tools. This partnership illustrates IMEXHS' strategic expansion in Latin America’s specialised healthcare sector and aligns with its new pricing structure aimed at enhancing profitability.
Key Points
  • IMEXHS signs new radiology services contract with Oncolife in Colombia
  • Contract focuses on high-complexity diagnostics for oncology patients
  • Deployment of RIS/PACS platform and AI diagnostic layers
  • One-year contract term starting immediately
  • Expected revenue contribution of A$1.4 million
  • Part of IMEXHS' strategy to expand in specialised healthcare segments
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.